HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

Advancements and Projections in the Global Cardiac Rhythm Management Devices Market: Insights, Trends, Opportunities, and ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

Stopping blood thinners before or during surgery for a CIED may result in little to no difference in undesirable outcomes such as blood clots or bleeding events when compared to taking them ...

When someone's heart stops pumping, early CPR can save their life. New survey research from the American Heart Association ...

The cardiac pacemaker market has witnessed significant growth over recent years, driven by the increasing prevalence of heart diseases, advancements in pacemaker technology, and growing awareness ...

NANS attendees are invited to visit booth #213 to learn more about how Integer can serve as a strategic partner of choice in amplifying customers’ innovation and increasing speed to market. More ...

"The integration of Lucia into UpBeat.org aligns perfectly with our mission to provide innovative resources for patients and ...

The Jacques-de Champlain Foundation is a charitable organization dedicated to increasing survival rates for cardiac arrest victims by optimizing access to and use of automated external defibrillators ...

Much has changed since the 2013 document came out, with new information on pacing devices, techniques, and more.

Trinity Health Muskegon has successfully implanted a new FDA-approved pacemaker that is offering hope for those with abnormal heart rhythms.